pH- and ion-sensitive polymers for drug delivery

Bibliography

• Alam MA, Ali R, Al-Jenoobi FI, et al. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates. Expert Opin Drug Deliv 2012;9:1419-40
   PubMed Web of Science ®Google Scholar
• Alani AW, Rao DA, Seidel R, et al. The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer. J Pharm Sci 2010;99:3473-85
   PubMed Web of Science ®Google Scholar
• Yoshida T, Kurimoto I, Yoshihara K, et al. Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus I: evaluation of solid dispersion formulations: Int J Pharm. 2012;428:18-24
   Google Scholar
• Sawada T, Kondo H, Nakashima H, et al. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy. Int J Pharm 2004;280:103-11
   PubMed Web of Science ®Google Scholar
• Katsuma M, Watanabe S, Kawai H, et al. Effects of absorption promoters on insulin absorption through colon-targeted delivery. Int J Pharm 2006;307:156-62
   PubMed Web of Science ®Google Scholar
• Tirpude RN, Puranik PK. Rabeprazole sodium delayed-release multiparticulates: effect of enteric coating layers on product performance. J Adv Pharm Technol Res 2011;2:184-91
   PubMedGoogle Scholar
• Lai TC, Bae Y, Yoshida T, et al. pH-sensitive multi-PEGylated block copolymer as a bioresponsive pDNA delivery vector. Pharm Res 2010;27:2260-73
   PubMed Web of Science ®Google Scholar
• Maeda A, Shinoda T, Ito T, et al. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating. Int J Pharm 2011;408:84-90
   PubMed Web of Science ®Google Scholar
• Yoshida T, Nakanishi K, Maeda A, et al. Pharmaceutical composition containing lipophilic IL-2 production inhibitor. WO2009054463; 2009
   Google Scholar
• Babish J, Tripp M, Howell T, Bland JS. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity. US7811610; 2010
   Google Scholar
• Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003;92:1343-55
   PubMed Web of Science ®Google Scholar
• Maeda H. The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci 2013; In press
   Web of Science ®Google Scholar
• Matsumura Y. Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect. Adv Drug Deliv Rev 2011;63:184-92
   PubMed Web of Science ®Google Scholar
• Mizumoto T, Tamura T, Kawai H, et al. Formulation design of an oral, fast-disintegrating dosage form containing taste-masked particles of famotidine. Chem Pharm Bull (Tokyo) 2008;56:946-50
   PubMed Web of Science ®Google Scholar
• Mizumoto T, Tamura T, Kawai H, et al. Formulation design of taste-masked particles, including famotidine, for an oral fast-disintegrating dosage form. Chem Pharm Bull (Tokyo) 2008;56:530-5
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tasaki H, Maeda A, et al. Mechanism of controlled drug release from a salting-out taste-masking system. J Control Release 2008;131:47-53
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tasaki H, Maeda A, et al. Salting-out taste-masking system generates lag time with subsequent immediate release. Int J Pharm 2009;365:81-8
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tasaki H, Maeda A, et al. Optimization of salting-out taste-masking system for micro-beads containing drugs with high solubility. Chem Pharm Bull (Tokyo) 2008;56:1579-84
   PubMed Web of Science ®Google Scholar
• Tasaki H, Yoshida T, Maeda A, et al. Effects of physicochemical properties of salting-out layer components on drug release. Int J Pharm 2009;376:13-21
   PubMedGoogle Scholar
• Kurimoto I, Kasashima Y, Kawai H, et al. Drug-containing coated microparticle for orally disintegrating tablet. WO2005039542; 2005
   Google Scholar
• Scaffidi-Domianello YY, Legin AA, Jakupec MA, et al. Synthesis, characterization, and cytotoxic activity of novel potentially pH-Sensitive nonclassical platinum(II) complexes featuring 1,3-dihydroxyacetone oxime ligands. Inorg Chem 2011;50:10673-81
   PubMed Web of Science ®Google Scholar
• Richards AC, Santini JR JT, Cima MJ, et al. Microchip devices for delivery of molecules and methods of fabrication thereof. US20020107470; 2002
   Google Scholar
• Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm 2009;71:431-44
   PubMed Web of Science ®Google Scholar
• Douroumis D. Orally disintegrating dosage forms and taste-masking technologies; 2010. Expert Opin Drug Deliv 2011;8:665-75
   PubMed Web of Science ®Google Scholar
• Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv 2007;4:417-26
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Tanaka M, Kishimoto H, et al. Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine. J Pharm Pharmacol 2002;54:1323-8
   PubMed Web of Science ®Google Scholar
• Randale SA, Dabhi CS, Tekade AR, et al. Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method. Chem Pharm Bull (Tokyo) 2010;58:443-8
   PubMed Web of Science ®Google Scholar
• Sheshala R, Khan N, Darwis Y. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate. Chem Pharm Bull (Tokyo) 2011;59:920-8
   PubMed Web of Science ®Google Scholar
• Yan YD, Woo JS, Kang JH, et al. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Biol Pharm Bull 2010;33:1364-70
   PubMed Web of Science ®Google Scholar
• Kayumba PC, Huyghebaert N, Cordella C, et al. Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue. Eur J Pharm Biopharm 2007;66:460-5
   PubMed Web of Science ®Google Scholar
• Haware RV, Chaudhari PD, Parakh SR, Bauer-Brandl A. Development of a melting tablet containing promethazine HCl against motion sickness. AAPS PharmSciTech 2008;9:1006-15
   PubMed Web of Science ®Google Scholar
• Tasaki H, Ishii T, Kasashima Y, et al. Orally disintegrating tablet. WO2011121824; 2011
   Google Scholar
• Shimamo K, Kondo O, Miwa A, et al. Evaluation of uniform-sized microparticles containing a vibration nozzle method. Drug Dev Ind Pharm 1995;21:331-47
   Google Scholar
• Lee JH, Choi G, Oh YJ, et al. A nanohybrid system for taste masking of sildenafil. Int J Nanomedicine 2012;7:1635-49
   PubMed Web of Science ®Google Scholar
• Johnson DA, Roach AC, Carlsson AS, et al. Stability of esomeprazole capsule contents after in vitro suspension in common soft foods and beverages. Pharmacotherapy 2003;23:731-4
   PubMed Web of Science ®Google Scholar
• Liu P, Sun B, Lu X, et al. HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule. Biomed Chromatogr 2007;21:89-93
   PubMed Web of Science ®Google Scholar
• Sharma M, Sharma V, Panda AK, Majumdar DK. Development of enteric submicron particles formulation of α-amylase for oral delivery. Pharm Dev Technol 2013;18(3):560-9
   PubMed Web of Science ®Google Scholar
• Sharma M, Sharma V, Panda AK, Majumdar DK. Development of enteric submicron particle formulation of papain for oral delivery. Int J Nanomedicine 2011;6:2097-111
   PubMed Web of Science ®Google Scholar
• Iemma F, Spizzirri UG, Puoci F, et al. pH-sensitive hydrogels based on bovine serum albumin for oral drug delivery. Int J Pharm 2006;312:151-7
   PubMed Web of Science ®Google Scholar
• Katsuma M, Watanabe S, Takemura S, et al. Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers. J Pharm Sci 2004;93:1287-99
   PubMed Web of Science ®Google Scholar
• Li J, Yang L, Ferguson SM, et al. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III. AAPS PharmSciTech 2002;3:E33
   PubMedGoogle Scholar
• Yang L, Watanabe S, Li J, et al. Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES). Pharm Res 2003;20:429-34
   PubMed Web of Science ®Google Scholar
• Katsuma M, Watanabe S, Kawai H, et al. Studies on lactulose formulations for colon-specific drug delivery. Int J Pharm 2002;249:33-43
   PubMed Web of Science ®Google Scholar
• Zimová L, Vetchý D, Muselík J, Stembírek J. The development and in vivo evaluation of a colon drug delivery system using human volunteers. Drug Deliv 2012;19:81-9
   PubMed Web of Science ®Google Scholar
• Takaya T, Sawada K, Suzuki H, et al. Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after administration to beagle dogs. J Drug Targeting 1997;4:271-6
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92
   PubMed Web of Science ®Google Scholar
• Rowinsky EK, Rizzo J, Ochoa L, et al. A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies. J Clin Oncol 2003;21:148-57
   PubMed Web of Science ®Google Scholar
• Zhou L, Cheng R, Tao H, et al. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice. Biomacromolecules 2011;12:1460-7
   PubMed Web of Science ®Google Scholar
• Kim D, Gao ZG, Lee ES, Bae YH. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol Pharm 2009;6:1353-62
   PubMed Web of Science ®Google Scholar
• Lee ES, Gao Z, Kim D, et al. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. J Control Release 2008;129:228-36
   PubMed Web of Science ®Google Scholar
• Gao ZG, Tian L, Hu J, et al. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles. J Control Release 2011;152:84-9
   PubMed Web of Science ®Google Scholar
• Seo K, Chung SW, Byun Y, Kim D. Paclitaxel loaded nano-aggregates based on pH sensitive polyaspartamide amphiphilic graft copolymers. Int J Pharm 2012;424:26-32
   PubMedGoogle Scholar
• Min KH, Kim JH, Bae SM, et al. Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy. J Control Release 2010;144:259-66
   PubMed Web of Science ®Google Scholar
• Wu XL, Kim JH, Koo H, et al. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjug Chem 2010;21:208-13
   PubMed Web of Science ®Google Scholar
• Devalapally H, Shenoy D, Little S, et al. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Cancer Chemother Pharmacol 2007;59:477-84
   PubMed Web of Science ®Google Scholar
• Etrych T, Mrkvan T, Chytil P, et al. N-(2-Hydroxypropyl)methacrylamide-Based Polymer Conjugates with pH-Controlled Activation of Doxorubicin. I. New Synthesis, Physicochemical Characterization and Preliminary Biological Evaluation. J Appl Polym Sci 2008;109:3050-61
   Web of Science ®Google Scholar
• Etrych T, Sírová M, Starovoytova L, et al. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Mol Pharm 2010;7:1015-26
   PubMed Web of Science ®Google Scholar
• Duncan R, Vicent MJ. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities. Adv Drug Deliv Rev 2010;62:272-82
   PubMed Web of Science ®Google Scholar
• Nowotnik DP, Cvitkovic E. ProLindac™ (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic. Adv Drug Deliv Rev 2009;61:1214-19
   PubMed Web of Science ®Google Scholar
• Jevsevar S, Kunstelj M, Porekar VG. PEGylation of therapeutic proteins. Biotechnol J 2010;5:113-28
   PubMed Web of Science ®Google Scholar
• Etrych T, Kovář L, Strohalm J, et al. Biodegradable star HPMA polymer-drug conjugates: biodegradability, distribution and anti-tumor efficacy. J Control Release 2011;154:241-8
   PubMed Web of Science ®Google Scholar
• Etrych T, Strohalm J, Chytil P, et al. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors. J Drug Target 2011;19:874-89
   PubMed Web of Science ®Google Scholar
• Bae Y, Fukushima S, Harada A, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed Engl 2003;42:4640-3
   PubMed Web of Science ®Google Scholar
• Bae Y, Nishiyama N, Kataoka K. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem 2007;18:1131-9
   PubMed Web of Science ®Google Scholar
• Mishra S, Webster P, Davis ME. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol 2004;83:97-111
   PubMed Web of Science ®Google Scholar
• Kim JK, Garripelli VK, Jeong UH, et al. Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery. Int J Pharm 2010;401:79-86
   PubMedGoogle Scholar
• Garripelli VK, Kim JK, Namgung R, et al. A novel thermosensitive polymer with pH-dependent degradation for drug delivery. Acta Biomater 2010;6:477-85
   PubMed Web of Science ®Google Scholar
• Chen W, Meng F, Cheng R, Zhong Z. pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles. J Control Release 2010;142:40-6
   PubMed Web of Science ®Google Scholar
• Cohen JA, Beaudette TT, Tseng WW, et al. T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem 2009;20:111-19
   PubMed Web of Science ®Google Scholar
• Standley SM, Mende I, Goh SL, et al. Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. Bioconjug Chem 2007;18:77-83
   PubMed Web of Science ®Google Scholar
• Tang R, Ji W, Wang C. Amphiphilic block copolymers bearing ortho ester side-chains: pH-dependent hydrolysis and self-assembly in water. Macromol Biosci 2010;10:192-201
   PubMed Web of Science ®Google Scholar
• Tang R, Ji W, Panus D, et al. Block copolymer micelles with acid-labile ortho ester side-chains: synthesis, characterization, and enhanced drug delivery to human glioma cells. J Control Release 2011;151:18-27
   PubMed Web of Science ®Google Scholar
• Lin S, Du F, Wang Y, et al. An acid-labile block copolymer of PDMAEMA and PEG as potential carrier for intelligent gene delivery systems. Biomacromolecules 2008;9:109-15
   PubMed Web of Science ®Google Scholar
• Shin J, Shum P, Thompson DH. Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J Control Release 2003;91:187-200
   PubMed Web of Science ®Google Scholar
• Xu Z, Gu W, Chen L, et al. A smart nanoassembly consisting of acid-labile vinyl ether PEG-DOPE and protamine for gene delivery: preparation and in vitro transfection. Biomacromolecules 2008;9:3119-26
   PubMed Web of Science ®Google Scholar
• Milletti F. Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 2012;17:850-60
   PubMed Web of Science ®Google Scholar
• El-Sayed A, Futaki S, Harashima H. Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: ways to Overcome Endosomal Entrapment. AAPS J 2009;11:13-22
   PubMed Web of Science ®Google Scholar
• Esbjörner EK, Oglecka K, Lincoln P, et al. Membrane binding of pH-sensitive influenza fusion peptides. positioning, configuration, and induced leakage in a lipid vesicle model. Biochemistry 2007;46:13490-504
   PubMed Web of Science ®Google Scholar
• Li W, Nicol F, Szoka FC Jr, et al. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 2004;56:967-85
   PubMed Web of Science ®Google Scholar
• Sasaki K, Kogure K, Chaki S, et al. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives. Anal Bioanal Chem 2008;391:2717-27
   PubMed Web of Science ®Google Scholar
• Deshayes S, Morris MC, Divita G, et al. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci 2005;62:1839-49
   PubMed Web of Science ®Google Scholar
• Min SH, Lee DC, Lim MJ, et al. A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA. J Gene Med 2006;8:1425-34
   PubMed Web of Science ®Google Scholar
• Pujals S, Fernández-Carneado J, López-Iglesias C, et al. Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Biochim Biophys Acta 2006;1758:264-79
   PubMed Web of Science ®Google Scholar
• Kämper N, Day PM, Nowak T, et al. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 2006;80:759-68
   PubMed Web of Science ®Google Scholar
• Lundberg P, El-Andaloussi S, Sutlu T, et al. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J 2007;21:2664-71
   PubMed Web of Science ®Google Scholar
• Pack DW, Hoffman AS, Pun S, et al. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005;4:581-93
   PubMed Web of Science ®Google Scholar
• Kim YH, Park JH, Lee M, et al. Polyethylenimine with acid-labile linkages as a biodegradable genecarrier. J Control Release 2005;103:209-19
   PubMed Web of Science ®Google Scholar
• Thomas M, Lu JJ, Ge Q, et al. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci 2005;102:5679-84
   PubMed Web of Science ®Google Scholar
• Tang GP, Guo HY, Alexis F, et al. Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system. J Gene Med 2006;8:736-44
   PubMed Web of Science ®Google Scholar
• Kichler A, Leborgne C, Danos O, et al. Characterization of the gene transfer process mediated by histidine-rich peptides. J Mol Med 2007;85:191-200
   PubMed Web of Science ®Google Scholar
• Hatefi A, Megeed Z, Ghandehari H. Recombinant polymer–protein fusion: a promising approach towards efficient and targeted gene delivery. J Gene Med 2006;8:468-76
   PubMed Web of Science ®Google Scholar
• Mason AJ, Martinez A, Glaubitz C, et al. The antibiotic and DNA transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J 2006;20:320-2
   PubMed Web of Science ®Google Scholar
• Ghosn B, Kasturi SP, Roy K. Enhancing polysaccharide-mediated delivery of nucleic acids through functionalization with secondary and tertiary amines. Curr Top Med Chem 2008;8:331-40
   PubMed Web of Science ®Google Scholar
• Ghosn B, Singh A, Li M, et al. Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA. Oligonucleotides 2010;20:163-72
   PubMed Web of Science ®Google Scholar
• Lin C, Zhong ZY, Lok MC, et al. Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjug Chem 2007;18:138-45
   PubMed Web of Science ®Google Scholar
• Mateos-Timoneda MA, Lok MC, Hennink WE, et al. Poly(amido amine)s as gene delivery vectors: effects of quaternary nicotinamide moieties in the side chains. ChemMedChem 2008;3:478-86
   PubMed Web of Science ®Google Scholar
• Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci 2009;98:3886-902
   PubMed Web of Science ®Google Scholar
• Nadkar S, Lokhande C. Current trends in novel drug delivery - An OTC perspective. Pharma Times 2010;42:17-23
   Google Scholar
• Bodmeier R, Guo X, Sarabia RE, Skultety PF. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D. Pharm Res 1996;13:52-6
   PubMed Web of Science ®Google Scholar
• Narisawa S, Nagata M, Hirakawa Y, et al. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid. J Pharm Sci 1996;85:184-8
   PubMed Web of Science ®Google Scholar
• Narisawa S, Nagata M, Danyoshi C, et al. An organic acid-induced sigmoidal release system for oral controlled-release preparations. Pharm Res 1994;11:111-16
   PubMed Web of Science ®Google Scholar
• Furyk S, Zhang Y, Ortiz-Acosta D, et al. Effects of end group polarity and molecular weight on the lower critical solution temperature of poly(N-isopropylacrylamide). J Polym Sci Part A: Polym Chem 2006;44:1492-501
   Web of Science ®Google Scholar
• Karewicz A, Zasada K, Szczubiałka K, et al. “Smart” alginate-hydroxypropylcellulose microbeads for controlled release of heparin. Int J Pharm 2010;385:163-9
   PubMedGoogle Scholar
• Crespy D, Rossi RM. Temperature-responsive polymers with LCST in the physiological range and their applications in textiles. Polymer Int 2007;56:1461-8
   Web of Science ®Google Scholar
• Yoshida T, Tasaki H, Katsuma M, et al. Timed-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition. EP1787640A1; 2007
   Google Scholar
• Hofmeister F. Zur Lehre von der Wirkung der Salze. Arch Exp Pathol Pharmakol 1888;24:247-60
   Google Scholar
• Park KH, Song HC, Na K, et al. Ionic strength-sensitive pullulan acetate nanoparticles (PAN) for intratumoral administration of radioisotope: ionic strength-dependent aggregation behavior and (99m)Technetium retention property. Colloids Surf B Biointerfaces 2007;59:16-23
   PubMed Web of Science ®Google Scholar
• Eeckman F, Moës AJ, Amighi K. Evaluation of a new controlled-drug delivery concept based on the use of thermoresponsive polymers. Int J Pharm 2002;241:113-25
   PubMed Web of Science ®Google Scholar
• Morihara M, Aoyagi N, Kaniwa N, et al. Assessment of gastric acidity of Japanese subjects over the last 15 years. Biol Pharm Bull 2001;24:313-15
   PubMed Web of Science ®Google Scholar
• Lafourcade C, Sobo K, Kieffer-Jaquinod S, et al. Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS ONE 2008;3:e2758
   PubMed Web of Science ®Google Scholar
• Marshansky V. The V-ATPase a2-subunit as a putative endosomal pH-sensor. Biochem Soc Trans 2007;35:1092-9
   PubMed Web of Science ®Google Scholar
• Hinton A, Sennoune SR, Bond S, et al. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. J Biol Chem 2009;284:16400-8
   PubMed Web of Science ®Google Scholar